文献速递糖尿病

糖尿病筛查:液相色谱-质谱法检测唾液1,5-脱水葡萄糖醇的发现与应用

Diabetes Screening: Detection and Application of Saliva 1,5-Anhydroglucitol by Liquid Chromatography-Mass Spectrometry.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究为基于人群的横断面研究,纳入641例无明确糖尿病史的中国受试者,用液相色谱-质谱法检测唾液1,5-脱水葡萄糖醇(1,5-AG),按美国糖尿病协会标准定义糖尿病。唾液1,5-AG与血清1,5-AG正相关、与血糖及糖化血红蛋白负相关,空腹血糖联合空腹唾液1,5-AG较单用空腹血糖减少47.22%需行口服葡萄糖耐量试验的人数。

要点

  • 糖尿病受试者唾液1,5-AG水平低于非糖尿病受试者(均P<.05)。
  • 唾液1,5-AG与血清1,5-AG正相关,与血糖和糖化血红蛋白负相关(均P<.05)。
  • 空腹血糖联合空腹唾液1,5-AG较单用空腹血糖减少47.22%需行口服葡萄糖耐量试验的人数。

核心结论

  • 唾液1,5-AG联合空腹血糖或糖化血红蛋白可提高糖尿病筛查效率。
  • 唾液1,5-AG在非空腹检测中稳定,是一种无创、便捷的糖尿病筛查工具。

研究设计与样本

  • 研究为基于人群的横断面研究,于2018年9月至2019年6月招募641例无明确糖尿病史的受试者。
  • 采用液相色谱-质谱法检测唾液1,5-AG,糖尿病按美国糖尿病协会标准定义。
  • 通过受试者工作特征曲线分析唾液1,5-AG的筛查效率,并依据约登指数确定最佳切点。

主要发现

  • 糖尿病受试者唾液1,5-AG水平低于非糖尿病受试者(均P<.05)。
  • 唾液1,5-AG与血清1,5-AG呈正相关,与血糖和糖化血红蛋白呈负相关(均P<.05)。
  • 唾液1,5-AG0筛查糖尿病的最佳切点为0.436 μg/mL(灵敏度63.58%,特异度60.61%)。
  • 唾液1,5-AG120筛查糖尿病的最佳切点为0.438 μg/mL(灵敏度62.25%,特异度60.41%)。
  • 空腹血糖联合空腹唾液1,5-AG较单用空腹血糖减少47.22%需行口服葡萄糖耐量试验的人数。

关键数值与推荐

  • 糖尿病按美国糖尿病协会标准定义。
  • 唾液1,5-AG0筛查最佳切点0.436 μg/mL,灵敏度63.58%,特异度60.61%。
  • 唾液1,5-AG120筛查最佳切点0.438 μg/mL,灵敏度62.25%,特异度60.41%。

临床怎么用

  • 唾液1,5-AG联合空腹血糖或糖化血红蛋白可提高糖尿病筛查效率(作者结论)。
  • 唾液1,5-AG在非空腹检测中稳定,可作为无创、便捷的糖尿病筛查工具(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Unlike other commonly used invasive blood glucose-monitoring methods, saliva detection prevents patients from suffering physical uneasiness. However, there are few studies on saliva 1,5-anhydroglucitol (1,5-AG) in patients with diabetes mellitus (DM). OBJECTIVE: This study aimed to evaluate the effectiveness of saliva 1,5-AG in diabetes screening in a Chinese population. DESIGN AND PARTICIPANTS: This was a population-based cross-sectional study. A total of 641 subjects without a valid diabetic history were recruited from September 2018 to June 2019. Saliva 1,5-AG was measured with liquid chromatography-mass spectrometry. MAIN OUTCOME MEASURES: DM was defined per American Diabetes Association criteria. The efficiency of saliva 1,5-AG for diabetes screening was analyzed by receiver operating characteristic curves, and the optimal cutoff point was determined according to the Youden index. RESULTS: Saliva 1,5-AG levels in subjects with DM were lower than those in subjects who did not have DM (both P < .05). Saliva 1,5-AG was positively correlated with serum 1,5-AG and negatively correlated with blood glucose and glycated hemoglobin (HbA1c) (all P < .05). The optimal cutoff points of saliva 1,5-AG0 and 1,5-AG120 for diabetes screening were 0.436 μg/mL (sensitivity: 63.58%, specificity: 60.61%) and 0.438 μg/mL (sensitivity: 62.25%, specificity: 60.41%), respectively. Fasting plasma glucose (FPG) combined with fasting saliva 1,5-AG reduced the proportion of people who required an oral glucose tolerance test by 47.22% compared with FPG alone. CONCLUSION: Saliva 1,5-AG combined with FPG or HbA1c improved the efficiency of diabetes screening. Saliva 1,5-AG is robust in nonfasting measurements and a noninvasive and convenient tool for diabetes screening.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jian C, Zhao A, Ma X, et al. Diabetes Screening: Detection and Application of Saliva 1,5-Anhydroglucitol by Liquid Chromatography-Mass Spectrometry. J Clin Endocrinol Metab. 2020. PMID: 32170297. doi:10.1210/clinem/dgaa114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。